Express Scripts (ESRX) 77.92 $ESRX
Halifax Announces Sale of Envision Pharma Group
BusinessWire - Wed Jul 06, 9:01AM CDT
Leading middle-market private equity firm, The Halifax Group ("Halifax"
, announced today that it has sold Envision Pharma Group ("Envision" to Ardian (the independent private investment company) and GHO Capital (a specialist healthcare investment company), who have partnered with Envision's existing leadership team to purchase the group. Terms of the transaction were not disclosed.
ESRX: 77.92 (+1.37)
Verint Presents New York Life and Express Scripts with 2016 Engage Global Customer Awards
BusinessWire - Wed Jul 06, 7:30AM CDT
--Express Scripts Receives "Highly Commendable" Award Distinction
ESRX: 77.92 (+1.37), VRNT: 32.79 (+0.85)
Insider Q&A: A model for more rational drug prices
By MATTHEW PERRONE - AP - Mon Jul 04, 10:01AM CDT
Rising drug prices are creating anxiety for patients, politicians and physicians across the country, with little relief in sight.
ESRX: 77.92 (+1.37)
INVESTOR NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit Against Express Scripts Holding Company and Encourages Investors With Losses to Contact the Firm
BusinessWire - Fri Jul 01, 8:00PM CDT
Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company" (Nasdaq: ESRX). Investors who purchased or otherwise acquired shares between February 24, 2015 and March 21, 2016 (the "Class Period", are encouraged to contact the firm in advance of the July 5, 2016 lead plaintiff motion deadline.
ESRX: 77.92 (+1.37)
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action against Express Scripts Holding Company (ESRX) and Lead Plaintiff Deadline July 5, 2016
ACCESSWIRE - Thu Jun 30, 9:08AM CDT
NEW YORK, NY / ACCESSWIRE / June 30, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court, Southern District of New York on behalf of those who purchased shares of Express Scripts Holding Company ("Express Scripts" or the "Company" (NASDAQ: ESRX) between February 24, 2015 and March 21, 2016 inclusive (the "Class Period".
ANTM: 132.15 (+2.71), ESRX: 77.92 (+1.37)
Express Scripts Set to Possibly Pullback After Yesterday's Rally of 2.59%
Comtex SmarTrend(R) - Wed Jun 29, 2:00PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $74.21 to a high of $76.09. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $75.86 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 77.92 (+1.37)
After Yesterday's Rally of 2.59% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jun 29, 1:58PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $74.21 to a high of $76.09. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $75.86 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 77.92 (+1.37)
Fitch Rates Express Scripts' Bonds 'BBB'; Outlook Stable
BusinessWire - Wed Jun 29, 9:42AM CDT
Fitch Ratings has assigned a 'BBB' rating to the new bonds due 2023, 2027, and 2046 issued by Express Scripts Holding Company (NYSE: ESRX). The Rating Outlook is Stable.
ESRX: 77.92 (+1.37)
Express Scripts Announces Tender Offers for Outstanding Debt Securities
PR Newswire - Wed Jun 29, 7:59AM CDT
Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts" today announced that it has commenced tender offers to purchase for cash the debt securities listed in the tables below (collectively, the "Securities" and each a "series".
ESRX: 77.92 (+1.37)
DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit Against Express Scripts Holding Company and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Jun 23, 10:41PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 23, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company" (NASDAQ: ESRX) concerning possible violations of federal securities laws between February 24, 2015 and March 21, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 5, 2016, lead plaintiff motion deadline.
ESRX: 77.92 (+1.37)
STOCK ALERT: Rosen Law Firm Reminds Express Scripts Holding Company Investors of Important July 5 Deadline in Class Action - ESRX
GlobeNewswire - Thu Jun 23, 3:04PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Express Scripts Holding Company securities (NASDAQ:ESRX) from February 24, 2015 through March 21, 2016, both dates inclusive (the "Class Period" of the important July 5, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Express Scripts investors under the federal securities laws.
ESRX: 77.92 (+1.37)
The Zacks Analyst Blog Highlights: Owens-Illinois, Discovery Communications, Qorvo and Express Scripts
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 8:30AM CDT
The Zacks Analyst Blog Highlights: Owens-Illinois, Discovery Communications, Qorvo and Express Scripts
ESRX: 77.92 (+1.37), QRVO: 56.02 (+1.65), OI: 17.44 (+0.50), DISCA: 25.62 (+0.21)
Watch for Express Scripts to Potentially Pullback After Gaining 1.24% Yesterday
Comtex SmarTrend(R) - Wed Jun 22, 12:14PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $74.34 to a high of $76.08. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $75.25 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 77.92 (+1.37)
Express Scripts Rises 1.24% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 22, 12:13PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $74.34 to a high of $76.08. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $75.25 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 77.92 (+1.37)
4 Stocks to Buy on Yellen's Valuation Warning
Swarup Gupta - Zacks Investment Research - Wed Jun 22, 9:59AM CDT
This is not the first time that Yellen has weighed in on equities being overvalued.
ESRX: 77.92 (+1.37), QRVO: 56.02 (+1.65), OI: 17.44 (+0.50), DISCA: 25.62 (+0.21)
5 Medical Stocks with Incredibly Low PEG Ratios
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 10:08AM CDT
Medical is attractive for value investors due to its resiliency during volatile phases on the back of strong fundamentals of the constituent companies.
PMC: 25.64 (+0.83), ESRX: 77.92 (+1.37), AIRM: 37.82 (+1.16), PRAH: 42.52 (+1.37), MGLN: 67.30 (+1.60)
Downgrade Alert for Express Scripts (ESRX)
Comtex SmarTrend(R) - Tue Jun 21, 3:20AM CDT
Express Scripts (NASDAQ:ESRX) was downgraded from Equal Weight to Underweight at Morgan Stanley today. The stock closed yesterday at $74.14 on volume of 4.2 million shares, below average daily volume of 4.6 million. Express Scripts, Inc is a full service pharmacy benefit management and specialty managed care company serving clients throughout North America. The Company's customers include managed care organizations, insurance carriers, third party administrators, employers, and union-sponsored benefit plans. Express provides pharmacy network management, formulary management, and other services.
ESRX: 77.92 (+1.37)
Favourable Commercial Environment Awaits MedImmune Anti-Flu Candidate - Research and Markets
BusinessWire - Mon Jun 20, 6:30AM CDT
Research and Markets has announced the addition of the "Anti-Infective Drug News Issue 340" report to their offering.
ESRX: 77.92 (+1.37)
EXPRESS SCRIPTS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Express Scripts Holding Company - ESRX
PR Newswire - Fri Jun 17, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 5, 2016 to file lead plaintiff applications in a securities class action lawsuit against Express Scripts Holding Company (NasdaqGS: ESRX), if they purchased the Company's securities between February 24, 2015 and March 21, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the Southern District of New York.
ESRX: 77.92 (+1.37)
Invest in These 5 GARP Stocks for Solid Returns (revised)
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 5:07PM CDT
Both strong earnings growth history and impressive earnings growth prospects in the coming years are the main concepts that GARP investors borrow from the growth investing strategy.
WHR: 171.38 (+3.50), ESRX: 77.92 (+1.37), AIRM: 37.82 (+1.16), DST: 119.52 (+2.88), LEA: 106.41 (+4.62)
Halifax Announces Sale of Envision Pharma Group
BusinessWire - Wed Jul 06, 9:01AM CDT
Leading middle-market private equity firm, The Halifax Group ("Halifax"
, announced today that it has sold Envision Pharma Group ("Envision" to Ardian (the independent private investment company) and GHO Capital (a specialist healthcare investment company), who have partnered with Envision's existing leadership team to purchase the group. Terms of the transaction were not disclosed. ESRX: 77.92 (+1.37)
Verint Presents New York Life and Express Scripts with 2016 Engage Global Customer Awards
BusinessWire - Wed Jul 06, 7:30AM CDT
--Express Scripts Receives "Highly Commendable" Award Distinction
ESRX: 77.92 (+1.37), VRNT: 32.79 (+0.85)
Insider Q&A: A model for more rational drug prices
By MATTHEW PERRONE - AP - Mon Jul 04, 10:01AM CDT
Rising drug prices are creating anxiety for patients, politicians and physicians across the country, with little relief in sight.
ESRX: 77.92 (+1.37)
INVESTOR NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit Against Express Scripts Holding Company and Encourages Investors With Losses to Contact the Firm
BusinessWire - Fri Jul 01, 8:00PM CDT
Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company"
(Nasdaq: ESRX). Investors who purchased or otherwise acquired shares between February 24, 2015 and March 21, 2016 (the "Class Period", are encouraged to contact the firm in advance of the July 5, 2016 lead plaintiff motion deadline. ESRX: 77.92 (+1.37)
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action against Express Scripts Holding Company (ESRX) and Lead Plaintiff Deadline July 5, 2016
ACCESSWIRE - Thu Jun 30, 9:08AM CDT
NEW YORK, NY / ACCESSWIRE / June 30, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court, Southern District of New York on behalf of those who purchased shares of Express Scripts Holding Company ("Express Scripts" or the "Company"
(NASDAQ: ESRX) between February 24, 2015 and March 21, 2016 inclusive (the "Class Period". ANTM: 132.15 (+2.71), ESRX: 77.92 (+1.37)
Express Scripts Set to Possibly Pullback After Yesterday's Rally of 2.59%
Comtex SmarTrend(R) - Wed Jun 29, 2:00PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $74.21 to a high of $76.09. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $75.86 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 77.92 (+1.37)
After Yesterday's Rally of 2.59% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jun 29, 1:58PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $74.21 to a high of $76.09. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $75.86 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 77.92 (+1.37)
Fitch Rates Express Scripts' Bonds 'BBB'; Outlook Stable
BusinessWire - Wed Jun 29, 9:42AM CDT
Fitch Ratings has assigned a 'BBB' rating to the new bonds due 2023, 2027, and 2046 issued by Express Scripts Holding Company (NYSE: ESRX). The Rating Outlook is Stable.
ESRX: 77.92 (+1.37)
Express Scripts Announces Tender Offers for Outstanding Debt Securities
PR Newswire - Wed Jun 29, 7:59AM CDT
Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts"
today announced that it has commenced tender offers to purchase for cash the debt securities listed in the tables below (collectively, the "Securities" and each a "series". ESRX: 77.92 (+1.37)
DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit Against Express Scripts Holding Company and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Jun 23, 10:41PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 23, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company"
(NASDAQ: ESRX) concerning possible violations of federal securities laws between February 24, 2015 and March 21, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 5, 2016, lead plaintiff motion deadline. ESRX: 77.92 (+1.37)
STOCK ALERT: Rosen Law Firm Reminds Express Scripts Holding Company Investors of Important July 5 Deadline in Class Action - ESRX
GlobeNewswire - Thu Jun 23, 3:04PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Express Scripts Holding Company securities (NASDAQ:ESRX) from February 24, 2015 through March 21, 2016, both dates inclusive (the "Class Period"
of the important July 5, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Express Scripts investors under the federal securities laws. ESRX: 77.92 (+1.37)
The Zacks Analyst Blog Highlights: Owens-Illinois, Discovery Communications, Qorvo and Express Scripts
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 8:30AM CDT
The Zacks Analyst Blog Highlights: Owens-Illinois, Discovery Communications, Qorvo and Express Scripts
ESRX: 77.92 (+1.37), QRVO: 56.02 (+1.65), OI: 17.44 (+0.50), DISCA: 25.62 (+0.21)
Watch for Express Scripts to Potentially Pullback After Gaining 1.24% Yesterday
Comtex SmarTrend(R) - Wed Jun 22, 12:14PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $74.34 to a high of $76.08. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $75.25 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 77.92 (+1.37)
Express Scripts Rises 1.24% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 22, 12:13PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $74.34 to a high of $76.08. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $75.25 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 77.92 (+1.37)
4 Stocks to Buy on Yellen's Valuation Warning
Swarup Gupta - Zacks Investment Research - Wed Jun 22, 9:59AM CDT
This is not the first time that Yellen has weighed in on equities being overvalued.
ESRX: 77.92 (+1.37), QRVO: 56.02 (+1.65), OI: 17.44 (+0.50), DISCA: 25.62 (+0.21)
5 Medical Stocks with Incredibly Low PEG Ratios
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 10:08AM CDT
Medical is attractive for value investors due to its resiliency during volatile phases on the back of strong fundamentals of the constituent companies.
PMC: 25.64 (+0.83), ESRX: 77.92 (+1.37), AIRM: 37.82 (+1.16), PRAH: 42.52 (+1.37), MGLN: 67.30 (+1.60)
Downgrade Alert for Express Scripts (ESRX)
Comtex SmarTrend(R) - Tue Jun 21, 3:20AM CDT
Express Scripts (NASDAQ:ESRX) was downgraded from Equal Weight to Underweight at Morgan Stanley today. The stock closed yesterday at $74.14 on volume of 4.2 million shares, below average daily volume of 4.6 million. Express Scripts, Inc is a full service pharmacy benefit management and specialty managed care company serving clients throughout North America. The Company's customers include managed care organizations, insurance carriers, third party administrators, employers, and union-sponsored benefit plans. Express provides pharmacy network management, formulary management, and other services.
ESRX: 77.92 (+1.37)
Favourable Commercial Environment Awaits MedImmune Anti-Flu Candidate - Research and Markets
BusinessWire - Mon Jun 20, 6:30AM CDT
Research and Markets has announced the addition of the "Anti-Infective Drug News Issue 340" report to their offering.
ESRX: 77.92 (+1.37)
EXPRESS SCRIPTS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Express Scripts Holding Company - ESRX
PR Newswire - Fri Jun 17, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF"
and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 5, 2016 to file lead plaintiff applications in a securities class action lawsuit against Express Scripts Holding Company (NasdaqGS: ESRX), if they purchased the Company's securities between February 24, 2015 and March 21, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the Southern District of New York. ESRX: 77.92 (+1.37)
Invest in These 5 GARP Stocks for Solid Returns (revised)
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 5:07PM CDT
Both strong earnings growth history and impressive earnings growth prospects in the coming years are the main concepts that GARP investors borrow from the growth investing strategy.
WHR: 171.38 (+3.50), ESRX: 77.92 (+1.37), AIRM: 37.82 (+1.16), DST: 119.52 (+2.88), LEA: 106.41 (+4.62)
